Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

Related Citations for PubMed (Select 21866629)

1.

[Improved therapeutic effectiveness by combining recombinant human RhoB with low-dose cisplatin in human lung cancer in nude mice].

Hu XH, Wu WF, Qing Y, Song LF, Huang W, Wu Y, Li Y, Wu XH.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2011 Jul;42(4):475-9. Chinese.

PMID:
21866629
2.

Loss of RhoB expression in human lung cancer progression.

Mazieres J, Antonia T, Daste G, Muro-Cacho C, Berchery D, Tillement V, Pradines A, Sebti S, Favre G.

Clin Cancer Res. 2004 Apr 15;10(8):2742-50.

3.

Suppression of lung cancer in murine model: treated by combination of recombinant human endostsatin adenovirus with low-dose cisplatin.

Bai RZ, Wu Y, Liu Q, Xie K, Wei YQ, Wang YS, Liu K, Luo Y, Su JM, Hu B, Liu JY, Li Q, Niu T, Zhao ZW, Yang L.

J Exp Clin Cancer Res. 2009 Mar 5;28:31. doi: 10.1186/1756-9966-28-31.

4.

Antitumor efficacy of the cytotoxic RNase, ranpirnase, on A549 human lung cancer xenografts of nude mice.

Lee I, Kalota A, Gewirtz AM, Shogen K.

Anticancer Res. 2007 Jan-Feb;27(1A):299-307.

5.

[Effects of a protein kinase C inhibitor combined with cisplatin on non-small cell lung cancer].

Gao ZQ, Han BH, Sha HF, Shi ZY, Yang XH, Feng JX.

Zhonghua Jie He He Hu Xi Za Zhi. 2010 Apr;33(4):284-8. Chinese.

PMID:
20646461
6.

PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.

Yuan Z, Yan F, Wang YS, Liu HY, Gou LT, Zhao XY, Lai ST, Deng HX, Li J, Ding ZY, Xiong SQ, Kan B, Mao YQ, Chen LJ, Wei YQ, Zhao X.

Cancer Chemother Pharmacol. 2009 Dec;65(1):13-25. doi: 10.1007/s00280-009-0998-5. Epub 2009 Apr 22.

PMID:
19387645
7.

Enhanced antitumor effect of combining interferon beta with TRAIL mediated by tumor-targeting adeno-associated virus vector on A549 lung cancer xenograft.

Wang Y, He L, He G, Kong Y, Liu X, Cai H, Liu X, Tan W.

Sheng Wu Gong Cheng Xue Bao. 2010 Jun;26(6):780-8.

PMID:
20815258
8.

Improved therapeutic effectiveness by combining recombinant CXC chemokine ligand 10 with Cisplatin in solid tumors.

Li G, Tian L, Hou JM, Ding ZY, He QM, Feng P, Wen YJ, Xiao F, Yao B, Zhang R, Peng F, Jiang Y, Luo F, Zhao X, Zhang L, Zhou Q, Wei YQ.

Clin Cancer Res. 2005 Jun 1;11(11):4217-24.

9.

Combination of low-dose cisplatin and recombinant xenogeneic endoglin as a vaccine induces synergistic antitumor activities.

Tan GH, Tian L, Wei YQ, Zhao X, Li J, Wu Y, Wen YJ, Yi T, Ding ZY, Kan B, Mao YQ, Deng HX, Li HL, Zou CH, Fu CH.

Int J Cancer. 2004 Nov 20;112(4):701-6.

PMID:
15382054
10.

Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model.

Jiang QQ, Fan LY, Yang GL, Guo WH, Hou WL, Chen LJ, Wei YQ.

BMC Cancer. 2008 Aug 16;8:242. doi: 10.1186/1471-2407-8-242.

11.

Enhanced antitumor effect of cisplatin in human NSCLC cells by tumor suppressor LKB1.

Ou W, Ye S, Yang W, Wang Y, Ma Q, Yu C, Shi H, Yuan Z, Zhong G, Ren J, Zhu W, Wei Y.

Cancer Gene Ther. 2012 Jul;19(7):489-98. doi: 10.1038/cgt.2012.18. Epub 2012 May 11.

PMID:
22576699
12.
13.

Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.

Tan Y, Sun X, Xu M, Tan X, Sasson A, Rashidi B, Han Q, Tan X, Wang X, An Z, Sun FX, Hoffman RM.

Clin Cancer Res. 1999 Aug;5(8):2157-63.

14.

[Examination of resistance of lung adenocarcinoma cells to cisplatin by technetium-99m methoxyisobutyl isonitrile].

Hu S, Hu CP, Liang CH.

Zhonghua Yi Xue Za Zhi. 2005 Jun 8;85(21):1493-8. Chinese.

PMID:
16061030
15.

Cisplatin-controlled p53 gene therapy for human non-small cell lung cancer xenografts in athymic nude mice via the CArG elements.

Wang WD, Li R, Chen ZT, Li DZ, Duan YZ, Cao ZH.

Cancer Sci. 2005 Oct;96(10):706-12.

PMID:
16232203
16.

Synergistic antitumor activity of TRAIL combined with chemotherapeutic agents in A549 cell lines in vitro and in vivo.

Fan QL, Zou WY, Song LH, Wei W.

Cancer Chemother Pharmacol. 2005 Feb;55(2):189-96. Epub 2004 Jul 29.

PMID:
15290100
17.

Sensitization of tumor-associated endothelial cell apoptosis by the novel vascular-targeting agent ZD6126 in combination with cisplatin.

Goto H, Yano S, Matsumori Y, Ogawa H, Blakey DC, Sone S.

Clin Cancer Res. 2004 Nov 15;10(22):7671-6.

18.
19.

[Suppression of colon cancer in murine model by recombinant human endostatin adenovirus and cisplatin].

Wang L, Yang L, Wu Y, Jing XR, Wang L, Liu HY, Li Q.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2011 Sep;42(5):616-20. Chinese.

PMID:
22007483
20.

[Antitumor effects of recombinant quail vascular endothelial growth factor receptor 2, as a vaccine, combined with cisplatin on LL/2 tumor model in mice].

Hou JM, Liu JY, Yang L, Zhao X, Tian L, Lei S, Mao YQ, Wen YJ, Wei YQ.

Ai Zheng. 2005 Apr;24(4):391-6. Chinese.

PMID:
15820058
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk